Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitively Normal”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableLooking for participantsNCT03507257
What this trial is testing

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Who this might be right for
Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University 850
Early research (Phase 1)Looking for participantsNCT05386914
What this trial is testing

Short Term Sirolimus Treatment and MRI of the Brain and Lungs

Who this might be right for
Genetic Predisposition to DiseaseHealthy Volunteers
University of Missouri-Columbia 205
Testing effectiveness (Phase 2)Looking for participantsNCT05331144
What this trial is testing

Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

Who this might be right for
Cognitively Normal Older AdultsHypertensionSubjective Cognitive Decline+1 more
Rong Zhang 180
Post-approval studies (Phase 4)Study completedNCT01142336
What this trial is testing

Effects of Simvastatin on Biomarkers

Who this might be right for
Alzheimer's Disease
University of Washington 49
Not applicableStudy completedNCT01962779
What this trial is testing

Sleep, Aging and Risk for Alzheimer's Disease

Who this might be right for
Sleep Disordered BreathingAlzheimer's Disease
NYU Langone Health 235
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Not applicableStudy completedNCT06364189
What this trial is testing

Inspiring Seniors Toward Exercise Promotion

Who this might be right for
Cognitively Normal Older Adults
University of North Carolina, Greensboro 54
Testing effectiveness (Phase 2)Study completedNCT02656498
What this trial is testing

[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Jae Seung Kim 135
Not applicableStudy completedNCT05604365
What this trial is testing

FearLess in Cognitively Intact Patients With Glioma

Who this might be right for
GliomaFear of Cancer
Virginia Commonwealth University 22
Not applicableStudy completedNCT01222351
What this trial is testing

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

Who this might be right for
Late Onset Alzheimer Disease
New York State Psychiatric Institute 161
Not applicableStudy completedNCT03814603
What this trial is testing

The Sleep Amyloid, Slow WAve Race and Ethnicity Study

Who this might be right for
Alzheimer Disease
NYU Langone Health 210
Post-approval studies (Phase 4)Study completedNCT00220896
What this trial is testing

Prevention of Postoperative Delirium With Donepezil

Who this might be right for
Cognitively Normal Elderly Individuals
Technical University of Munich 37
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Not applicableStudy completedNCT03053908
What this trial is testing

Orexin and Tau Pathology in Cognitively Normal Elderly

Who this might be right for
ElderlyAlzheimer Disease
NYU Langone Health 25
Not applicableStudy completedNCT05441865
What this trial is testing

Cardiovascular Risk Factors and Cognitive Trajectories

Who this might be right for
Normal CognitionCardiovascular Risk FactorsCognitive Change+2 more
Peking University Sixth Hospital 3,372
Not applicableUnknownNCT05225181
What this trial is testing

Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly

Who this might be right for
Cognitively-normalMild Cognitive ImpairmentSubjective Cognitive Decline
Chang Gung Memorial Hospital 90
Not applicableStudy completedNCT02472899
What this trial is testing

Biomarker Study for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Beersheva Mental Health Center 115
Not applicableStudy completedNCT00977418
What this trial is testing

Brain and Cognitive Changes After Reasoning or Physical Training in Cognitively Normal Seniors

Who this might be right for
Hearing Impaired
The University of Texas at Dallas 60
Large-scale testing (Phase 3)Looking for participantsNCT07115238
What this trial is testing

Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD

Who this might be right for
Alzheimer DiseaseNeurofibrillary Tangle
Sinotau Pharmaceutical Group 354
Early research (Phase 1)Study completedNCT05164536
What this trial is testing

Plasma P-tau2017 and Quantitative Amyloid PET Imaging

Who this might be right for
Alzheimer Disease
Invicro 140
Load More Results